Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Multiple Sclerosis, Menstrual Cycle and Physical Acivity [NA]
The clinical trial investigating the relationship between the menstrual cycle and physical activity in individuals with multiple sclerosis h…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real Life
An ongoing French clinical trial comparing the 2024 and 2017 McDonald criteria for diagnosing multiple sclerosis in real-world practice; rec…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study (Phase 1) [NA]
This document outlines a Phase 1 protocol for an educational program aimed at improving quality of life and psychosocial outcomes in women w…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2) [NA]
This entry describes the ADVICE Protocol, a Phase 2 clinical trial evaluating educational programs based on healthy habits to improve qualit…
-
CLINICAL_TRIALS withdrawal · 2026-03-24Clinical Trial Update: Context- and Terrain-aware Gait Analysis
A University of Leeds clinical trial evaluating context- and terrain-aware gait analysis in Parkinson's disease, dementia, and related condi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS
A clinical trial in recruitment evaluating urinary incontinence and pelvic floor muscle activity in individuals with multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity
This clinical trial aims to identify factors related to urinary incontinence in patients with multiple sclerosis. It also involves EMG asses…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Motor Imagery and Action Observation for Gait Function in MS [NA]
A recruiting clinical trial at Hacettepe University is evaluating motor imagery and action observation as a way to improve gait function in …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS [NA]
A clinical trial investigating neuromodulation of cortical regions to treat neurogenic bladder in people with multiple sclerosis is currentl…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis
SYSNAV reports a recruiting study examining specific gait patterns in people with Multiple Sclerosis, with healthy adults included as contro…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Investigating the Impact of Sex Hormones in Multiple Sclerosis
Clinical trial update investigating the impact of sex hormones on multiple sclerosis; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Effects of Pelvic Floor Strengthening and Relaxation Exercises in Women Diagnosed With Multiple Sclerosis [NA]
A completed clinical trial from Gazi University assessed the effects of pelvic floor strengthening and relaxation exercises in women with mu…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition
This clinical trial update describes a novel wearable digital biomarker designed to detect changes in multiple sclerosis disease status, wit…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Ketamine for Multiple Sclerosis Fatigue [Phase 2]
Phase 2 clinical trial evaluating ketamine for fatigue in people with multiple sclerosis; currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: mHealth Effect on Multiple Sclerosis Patients' Quality of Life and Self-care Practices [NA]
A completed clinical trial from Cairo University evaluating the impact of mobile health tools on quality of life and self-care in people wit…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Intermittent Hypoxia in Persons With Multiple Sclerosis [NA]
A clinical trial update indicates a study evaluating intermittent hypoxia in people with Multiple Sclerosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden
An observational trial update from Bayer describes exposure to interferon-beta during the second and third trimesters in pregnant women in F…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS) [Phase 3]
A Phase 3 pediatric study evaluating the safety of diroximel fumarate and dimethyl fumarate and their effect on relapses in relapsing forms …
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: MS Relapses During COVID-19 Pandemic
A completed clinical trial studying relapses in multiple sclerosis during the COVID-19 pandemic.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis [NA]
This clinical trial from Nantes University Hospital investigates how genetic and transcriptomic factors contribute to poor outcomes in multi…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment [NA]
A clinical trial update describes ongoing evaluation of upper limb cryoneurolysis for shoulder pain and functional problems caused by spasti…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Prevalence of Periodontitis in Egyptian Multiple Sclerosis Patients.
A completed clinical trial from Cairo University evaluating the prevalence of periodontitis in Egyptian patients with multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis [NA]
A clinical trial update from the University of Alabama at Birmingham examines how meal timing may affect neurological health in adults with …
-
EMA approval · 2026-03-17EMA Authorised: Plegridy (peginterferon beta-1a) — Biogen Netherlands B.V.
The EMA authorised Plegridy (peginterferon beta-1a) from Biogen Netherlands B.V. for the treatment of multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Effect of Acetominophen an Gait Fatigue in Multiple Sclerosis
A clinical trial update evaluating the effect of acetaminophen on gait fatigue in people with multiple sclerosis, with the study currently n…